1. Building personalized cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia;Alfano;Am. Soc. Clin. Oncol. Educ. Book,2019
2. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur. Urol.,2017
3. M. Babjuk, W. Oosterlinck, R. Sylvester,; E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt EAU Guidelines on Non-Muscle-Invasive Bladder Cancer Available online: 〈https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/?type=archive〉 (accessed on 7 May 2021).
4. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer Available online: 〈https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/?type=archive〉 (accessed on 7 May 2021).
5. M. Babjuk (Chair), M. Burger (Vice-chair), E. Compérat,; P. Gontero, A.H. Mostafid, J. Palou, B.W.G. van Rhijn,; M. Rouprêt, S.F. Shariat, R. Sylvester, R. Zigeuner; Guidelines Associates: O. Capoun, D. Cohen,; J.L. Dominguez Escrig, B. Peyronnet, T. Seisen, V. Soukup EAU Guidelines on Non-Muscle-Invasive Bladder Cancer Available online: 〈https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/?type=archive〉 (accessed on 7 May 2021).